245 related articles for article (PubMed ID: 9831326)
1. Sulochrin inhibits eosinophil activation and chemotaxis.
Ohashi H; Motegi Y; Kita H; Gleich GJ; Miura T; Ishikawa M; Kawai H; Fukamachi H
Inflamm Res; 1998 Oct; 47(10):409-15. PubMed ID: 9831326
[TBL] [Abstract][Full Text] [Related]
2. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK
Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438
[TBL] [Abstract][Full Text] [Related]
3. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
Coëffier E; Joseph D; Vargaftig BB
J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
[TBL] [Abstract][Full Text] [Related]
4. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
[TBL] [Abstract][Full Text] [Related]
5. Cellular adhesion is required for effector functions of human eosinophils via G-protein coupled receptors.
Fujiu T; Kato M; Kimura H; Tachibana A; Suzuki M; Nako Y; Morikawa A
Ann Allergy Asthma Immunol; 2002 Jul; 89(1):90-8. PubMed ID: 12141728
[TBL] [Abstract][Full Text] [Related]
6. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG.
Bartemes KR; McKinney S; Gleich GJ; Kita H
J Immunol; 1999 Mar; 162(5):2982-9. PubMed ID: 10072549
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
Iwamoto I; Tomoe S; Tomioka H; Yoshida S
J Immunol; 1993 Aug; 151(4):2116-23. PubMed ID: 7688393
[TBL] [Abstract][Full Text] [Related]
8. Effects of ZCR-2060 on allergic airway inflammation and cell activation in guinea-pigs.
Abe T; Yoshida K; Omata T; Segawa Y; Matsuda K; Nagai H
J Pharm Pharmacol; 1994 Nov; 46(11):876-82. PubMed ID: 7897591
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of glucocorticoids on rat eosinophil superoxide generation and chemotaxis.
Sugimoto Y; Ogawa M; Tai N; Kamei C
Int Immunopharmacol; 2003 Jun; 3(6):845-52. PubMed ID: 12781701
[TBL] [Abstract][Full Text] [Related]
10. Pimecrolimus reduces eosinophil activation associated with calcium mobilization.
Plager DA; Henke SA; Matsuwaki Y; Madaan A; Squillace DL; Dierkhising RA; Kita H
Int Arch Allergy Immunol; 2009; 149(2):119-26. PubMed ID: 19127068
[TBL] [Abstract][Full Text] [Related]
11. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
Takafuji S; Tadokoro K; Ito K; Nakagawa T
Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.
Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA
Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583
[TBL] [Abstract][Full Text] [Related]
13. Effects of ortho-substituent groups of sulochrin on inhibitory activity to eosinophil degranulation.
Ohashi H; Ueno A; Nakao T; Ito J; Kimura K; Ishikawa M; Kawai H; Iijima H; Osawa T
Bioorg Med Chem Lett; 1999 Jul; 9(14):1945-8. PubMed ID: 10450959
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C inhibition enhances platelet-activating factor-induced eicosanoid production in human eosinophils.
Dent G; Muñoz NM; Rühlmann E; Zhu X; Leff AR; Magnussen H; Rabe KF
Am J Respir Cell Mol Biol; 1998 Jan; 18(1):136-44. PubMed ID: 9448055
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
Erger RA; Casale TB
Am J Respir Cell Mol Biol; 1995 Jan; 12(1):65-70. PubMed ID: 7811471
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate.
Kita H; Abu-Ghazaleh RI; Gleich GJ; Abraham RT
J Immunol; 1991 Apr; 146(8):2712-8. PubMed ID: 1707917
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-12 inhibits eosinophil degranulation and migration but does not promote eosinophil apoptosis.
Davoine F; Ferland C; Chakir J; Lee JE; Adamko DJ; Moqbel R; Laviolette M
Int Arch Allergy Immunol; 2006; 140(4):277-84. PubMed ID: 16735797
[TBL] [Abstract][Full Text] [Related]
18. Priming of eosinophil recruitment in vivo by LPS pretreatment.
Macari DM; Teixeira MM; Hellewell PG
J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
Casale TB; Erger RA; Little MM
Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
[TBL] [Abstract][Full Text] [Related]
20. Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni.
Moqbel R; Macdonald AJ; Cromwell O; Kay AB
Immunology; 1990 Mar; 69(3):435-42. PubMed ID: 2312166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
